Page 3 of articles about PRRS in Press releases

Fostera™ PRRS*, a modified-live vaccine for growing pigs from Pfizer Animal Health, brings a new high standard of innovation to the costly battle against porcine reproductive and respiratory syndrome (PRRS) respiratory disease.

Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) concluded the referral procedure for PORCILIS® PRRS and for PORCILIS® M Hyo on simultaneous administration of these products in piglets

HIPRA PHILIPPINES INC. celebrated l its AMERVAC®PRRS DAY II with the theme “High Protection for High Productivity and High Profitability". The event was composed of interesting topics from HIPRA’S own foreign as well as local technical experts in pig diseases and production.

Despite years of hard work by scientists, researchers, practicing veterinarians, pork producers, animal health companies, and others, Porcine Reproductive and Respiratory Syndrome (PRRS) remains a costly, frustrating challenge to the global swine industry.

A new disease which poses as great a risk as foot-and-mouth disease could devastate the British pig industry unless controls are tightened up.

PRRS X3 test delivers 99.9% specificity and 90% reduction of false positives